Istituto di Neurobiologia e Medicina Molecolare, Consiglio Nazionale delle Ricerche, Rome, Italy.
Ann Ist Super Sanita. 2011;47(3):284-9. doi: 10.4415/ANN_11_03_08.
The aim of this study was to investigate the effect of nerve growth factor (NGF) administration on retinal ganglion cells (RGCs) in experimentally induced glaucoma (GL) and diabetic retinopathy (DR). GL was induced in adult rats by injection of hypertonic saline into the episcleral vein of the eye and diabetes (DT) was induced by administration of streptozoticin. Control and experimental rats were treated daily with either ocular application of NGF or vehicle solution. We found that both animal models present a progressive degeneration of RGCs and changing NGF and VEGF levels in the retina and optic nerve. We then proved that NGF eye drop administration exerts a protective effect on these models of retinal degeneration. In brief, our findings indicate that NGF can play a protective role against RGC degeneration occurring in GL and DR and suggest that ocular NGF administration might be an effective pharmacological approach.
本研究旨在探讨神经生长因子(NGF)给药对实验性诱导的青光眼(GL)和糖尿病视网膜病变(DR)中视网膜神经节细胞(RGC)的影响。通过向眼巩膜静脉内注射高渗盐水诱导成年大鼠发生 GL,通过给予链脲佐菌素诱导糖尿病(DT)。对照和实验组大鼠每日分别接受 NGF 眼部滴注或载体溶液治疗。我们发现,这两种动物模型的 RGC 均呈现进行性退化,视网膜和视神经中 NGF 和 VEGF 水平发生变化。随后我们证明,NGF 滴眼剂给药对这些视网膜变性模型具有保护作用。总之,我们的研究结果表明,NGF 可能在 GL 和 DR 中 RGC 变性中发挥保护作用,并提示眼部 NGF 给药可能是一种有效的药物治疗方法。